<DOC>
	<DOCNO>NCT00535665</DOCNO>
	<brief_summary>A single center , randomize double-blind phase II clinical trial conduct adult evaluate safety immunogenicity inactivate pandemic influenza vaccine ( whole-virion , aluminium-adjuvanted ) .</brief_summary>
	<brief_title>Safety Immunogenicity Inactivated Pandemic Influenza Vaccine</brief_title>
	<detailed_description>The vaccine investigate producted embryonated hen 's egg use H5N1 reference strain NIBRG-14 prepare NIBSC . The strain reassortant A/Vietnam/1194/2004 A/PR/8/34 reverse genetics . Total 400 volunteer age 18 60 year old enrol 100 subject group . The eligible volunteer receive two dos vaccine 5μg，10μg 15μg haemagglutinin antigen . The schedule day 0,14 day 0,28 . The subject donate blood sample detection HI antibody microneutralization antibody . Local systematic adverse reaction record study .</detailed_description>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Healthy adult age 1860 year old Be able show legal identity card sake recruitment Be able understand sign inform consent . Woman： Who breastfeed plan become pregnant 56 day study participation Any history allergic reaction allergic component vaccine , eggs ovalbumin ; Any history severe adverse reaction vaccine , anaphylaxis , hive , respiratory difficulty , angioedema , abdominal pain Autoimmune disease immunodeficiency Asthma unstable require emergent care , hospitalization intubation past two year require use oral intravenous corticosteroid Diabetes mellitus ( type I II ) , exception gestational diabetes History thyroidectomy thyroid disease require medication within past 12 month Serious angioedema episode within previous 3 year require medication previous two year Hypertension well control medication 145/95 mmHg enrollment Bleeding disorder diagnose doctor ( e.g . factor deficiency , coagulopathy , platelet disorder require special precaution ) significant bruise bleed difficulty IM injection blood draw Active malignancy treat malignancy reasonable assurance sustain cure malignancy likely recur period study Seizure disorder : 1 . Febrile seizures age two year old , 2 . Seizures secondary alcohol withdrawal 3 year ago , 3 . A singular seizure require treatment within last 3 year Asplenia , functional asplenia condition result absence removal spleen GuillainBarre Syndrome Women subject positive urinary pregnancy test Any history immunosuppressive medication cytotoxic medication inhale corticosteroid within past six month ( exception corticosteroid nasal spray allergic rhinitis topical corticosteroid acute uncomplicated dermatitis ) History blood product administration within 3 month dose Administration investigational research agent within 30 day dose Administration live attenuate vaccine within 30 day dose Administration subunit inactivate vaccine , e.g . pneumococcal vaccine , allergy treatment antigen injection , within 14 day dose Be receive antiTB prophylaxis therapy currently Axillary temperature &gt; 37.0 centigrade time dose Psychiatric condition precludes compliance protocol ; past present psychosis ; past present bipolar disorder require therapy well control medication past two year ; disorder require lithium ; suicidal ideation occur within five year prior enrollment Any medical , psychiatric , social condition , occupational reason responsibility , judgment investigator , contraindication protocol participation impair volunteer 's ability give inform consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>November 2007</verification_date>
</DOC>